SGLT-2 inhibitors are a class of drugs that prevent kidney reabsorption of sugar and thus lower blood sugar levels
Creating a triple agonist was a major challenge
Tirzepatides success as a dual GLP-1/GIP agonist is leading the way for next-generation multi-receptor agonists, and companies are exploring oral formulations pills to win over patients averse to injections
GLP-1 also affects the brain, signaling satiety and reducing appetite, which is why its often targeted in weight-management therapies, Dr
The most common side effects are gastrointestinal, such as nausea, constipation, diarrhea, and decreased appetite
If you have a phobia of needles or find the thought of injecting yourself weekly an inconvenience, the Wegovy pill may be more suitable and appealing